Used as a key intermediate in the synthesis of biologically active compounds, particularly in pharmaceutical research. It serves as a building block for kinase inhibitors and other targeted therapies in oncology. Its halogenated structure allows for selective cross-coupling reactions, enabling the introduction of various functional groups during drug development. Commonly employed in the preparation of pyrazolopyridine derivatives that exhibit antiviral, anti-inflammatory, or antitumor activity. Also utilized in medicinal chemistry for structure-activity relationship (SAR) studies due to its ability to modulate binding affinity and metabolic stability.